2171

COM:CARSGEN

CARsgen Therapeutics

  • Stock

Last Close

6.71

08/11 08:08

Market Cap

2.36B

Beta: -

Volume Today

85.30M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
341.50K
-
average payables
average receivables
11.32M
-
book value per share
-1.29
-
-2.95
128.79%
7.75
362.21%
4.48
42.12%
3.24K
72,160.36%
capex per share
-0.18
-
-0.03
81.89%
-0.46
1,296.99%
-0.25
45.53%
-17.17
6,733.18%
capex to depreciation
-5.29
-
-0.47
91.16%
-3.40
628.45%
-1.70
50.04%
-0.11
93.57%
capex to operating cash flow
0.58
-
0.06
89.02%
0.35
448.74%
0.22
38.12%
0.02
90.26%
capex to revenue
-6.91
-
cash per share
0.17
-
1.84
981.07%
7.77
322.84%
4.11
47.11%
3.33K
80,797.64%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.26
-
0.08
69.11%
0.10
20.60%
0.04
55.17%
0.04
12.67%
debt to equity
-0.12
-
-0.06
48.03%
0.11
288.59%
0.05
57.19%
0.05
2.06%
dividend yield
earnings yield
-0.02
-
-0.13
528.44%
-0.55
333.80%
-0.12
77.85%
-0.24
95.19%
enterprise value
15.17B
-
13.36B
11.92%
8.33B
37.66%
5.22B
37.31%
-1.76B
133.73%
enterprise value over ebitda
-73.49
-
-46.69
36.47%
-16.08
65.55%
-6.58
59.11%
2.46K
37,534.68%
ev to operating cash flow
-84.74
-
-45.27
46.58%
-16.26
64.09%
-8.12
50.06%
3.87
147.68%
ev to sales
322.67
-
free cash flow per share
-0.50
-
-0.55
11.12%
-1.79
222.77%
-1.42
20.65%
-835.22
58,841.89%
free cash flow yield
-0.02
-
-0.02
17.94%
-0.08
262.56%
-0.11
33.31%
-146.78
138,290.58%
graham net net
-1.70
-
-3.33
96.17%
6.46
294.15%
3.59
44.46%
2.54K
70,671.30%
graham number
3.95
-
14.53
268.07%
46.24
218.22%
12.77
72.37%
313.08
2,350.95%
income quality
0.68
-
0.28
58.92%
0.11
61.01%
0.72
567.31%
0.61
15.66%
intangibles to total assets
0.11
-
0.02
77.68%
0.01
68.39%
0.01
0.51%
0.01
12.23%
interest coverage
-256.37
-
-24.26
90.54%
-53.91
122.22%
-56.78
5.32%
interest debt per share
0.15
-
0.20
33.47%
0.90
349.92%
0.24
72.87%
153.24
62,531.02%
inventory turnover
invested capital
-0.12
-
-0.06
48.03%
0.11
288.59%
0.05
57.19%
0.05
2.06%
market cap
15.18B
-
14.30B
5.78%
8.68B
39.30%
7.37B
15.11%
3.16M
99.96%
net current asset value
-943.41M
-
-1.87B
98.66%
2.56B
236.69%
2.01B
21.50%
1.42B
29.51%
net debt to ebitda
0.06
-
3.29
5,496.13%
0.68
79.29%
2.71
296.79%
2.47K
91,034.17%
net income per share
-0.54
-
-3.18
492.13%
-12.26
286.19%
-1.62
86.81%
-1.34
16.87%
operating cash flow per share
-0.32
-
-0.52
64.88%
-1.32
154.58%
-1.17
11.98%
-818.04
70,074.33%
payables turnover
receivables turnover
research and ddevelopement to revenue
19.44
-
return on tangible assets
-1.05
-
-1.47
40.53%
-1.36
7.40%
-0.33
76.14%
-0.00
99.90%
revenue per share
0.07
-
roe
0.42
-
1.07
158.81%
-1.58
247.28%
-0.36
77.21%
-0.00
99.88%
roic
0.41
-
0.36
13.07%
-0.17
147.85%
-0.33
91.59%
-0.00
99.87%
sales general and administrative to revenue
2.55
-
shareholders equity per share
-1.29
-
-2.95
128.79%
7.75
362.21%
4.48
42.12%
3.24K
72,160.36%
stock based compensation to revenue
0.52
-
tangible asset value
-768.07M
-
-1.71B
122.19%
2.97B
274.02%
2.45B
17.43%
1.79B
27.14%
tangible book value per share
-1.35
-
-3.01
122.19%
7.68
355.22%
4.45
42.10%
3.21K
72,170.13%
working capital
-906.37M
-
910.56M
200.46%
2.68B
194.51%
2.13B
20.59%
1.68B
21.26%

All numbers in (except ratios and percentages)